Tocotrienols & Metabolic Research

Explore published studies examining tocotrienols in relation to metabolic syndrome and its associated factors. Visit each source for its methods, findings, and limitations.

References

Delta-Tocotrienol in Combination with Resveratrol Improves the Cardiometabolic Risk Factors and Biomarkers in Patients with Metabolic Syndrome: A Randomized Controlled Trial (2022)

https://pubmed.ncbi.nlm.nih.gov/36125447/

Effects of Delta- Tocotrienol supplementation on Glycemic Control, oxidative stress, inflammatory biomarkers and miRNA expression in type 2 diabetes mellitus: A randomized control trial (2021) https://pubmed.ncbi.nlm.nih.gov/33899292/ 

Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial (2020) https://www.sciencedirect.com/science/article/abs/pii/S0965229920300777?utm_source=chatgpt.com

Pilot study finds evidence that annatto-based tocotrienols support liver-related biomarkers (2020) https://www.nutritionaloutlook.com/view/pilot-study-finds-evidence-that-annatto-based-tocotrienols-support-liver-related-biomarkers?utm_source=chatgpt.com

A 12-week evaluation of aAnnatto Tocotrienol supplementation for postmenopausal women: safety, quality of life, body composition, physical activity, and nutrient intake (2018)

https://pmc.ncbi.nlm.nih.gov/articles/PMC6022510/?utm_source=chatgpt.com

Acute Effects of Tocotrienols on Insulin Sensitivity and Metabolic Risk Markers in Individuals at Risk for Metabolic Syndrome (2015)

https://www.clinicaltrials.gov/study/NCT01626430?utm_source=chatgpt.com&tab=history

Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (1991) https://pubmed.ncbi.nlm.nih.gov/2012010/